SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001104659-20-068349
Filing Date
2020-06-01
Accepted
2020-06-01 16:14:41
Documents
4
Group Members
D. E. SHAW & CO., L.L.C.DAVID E. SHAW

Document Format Files

Seq Description Document Type Size
1 SC 13G tm2021497d1_sc13g.htm SC 13G 60595
2 EXHIBIT 1 tm2021497d1_ex1.htm EX-99.1 6001
3 EXHIBIT 2 tm2021497d1_ex2.htm EX-99.2 6030
4 EXHIBIT 3 tm2021497d1_ex3.htm EX-99.3 7504
  Complete submission text file 0001104659-20-068349.txt   81795
Mailing Address 21 FIRSTFIELD ROAD GAITHERSBURG MD 20878
Business Address 21 FIRSTFIELD ROAD GAITHERSBURG MD 20878 240-268-2000
NOVAVAX INC (Subject) CIK: 0001000694 (see all company filings)

IRS No.: 222816046 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-48948 | Film No.: 20933556
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 1166 AVENUE OF THE AMERICAS NINTH FLOOR NEW YORK NY 10036
Business Address 1166 AVENUE OF THE AMERICAS NINTH FLOOR NEW YORK NY 10036 2124780000
D. E. SHAW & CO, L.P. (Filed by) CIK: 0001009268 (see all company filings)

IRS No.: 133695715 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G